Antibiotic resistance patterns of Acinetobacter species isolated in King Hussein Medical Center, Jordan

Saudi Medical Journal

Volumn 26, Issue 1, 2005, Pages 153-155

  Abu Setteh, Mohammad H ^a  

^a KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBENICILLIN; CEFAZOLIN; CEFEPIME; CEFSULODIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MINOCYCLINE; MONOBACTAM DERIVATIVE; NETILMICIN; PEFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TICARCILLIN; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER LWOFFII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD ANALYSIS; CONTROLLED STUDY; HUMAN; JORDAN; MULTIDRUG RESISTANCE; NONHUMAN; SPUTUM ANALYSIS; URINALYSIS; WOUND INFECTION;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; JORDAN;

EID: 14944352306     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Saraçli MA, Aydogan H, Özyurt M, Küçükkaraaslan A, Basustaoglu A. Antibiotic resistance pattern of Acinetobacter species isolated in our hospital. Gülhane Medical Journal 2001; 43: 20-24.
2. Bouvet PJM, Grimont PAD. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus. Int J Syst Bacteriol 1986; 36, 228-240.
3. Seifert H, Baginski R, Schulze A, Pulverer G. Antimicrobial susceptibility of Acinetobacter species. Antimicrobial Agents Chemother 1993; 37: 750-753.
4. Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother 2002; 49: 479-487.
5. Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect 2002; 8: 144-153.
6. Vila J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig R, et al. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii Antimicrob Agents Chemother 1993; 37: 138-141.
7. Turner PJ, Greenhalgh JM, and the MYSTIC study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 2003; 9: 563-567.